share_log

美高梅中國：自願公告

MGM CHINA: VOLUNTARY ANNOUNCEMENT

香港交易所 ·  Mar 20 05:02
Summary by Moomoo AI
美高梅中國於2024年3月15日宣佈，與其控股股東美高梅國際酒店集團（MRI）簽訂取消函件，自願取消原訂立於2022年11月10日的融通協議下全部7.5億美元的未動用承諾金額。該融通協議於2024年3月20日正式終止，雙方無需承擔任何法律責任，但需按協議條款支付承諾費。此舉是因應澳門放寬COVID-19旅遊限制後市場顯著復甦，以及公司2023年收益大幅增長，故公司商業上無需提取該融通。董事會認為此決定符合公司及股東整體利益，且融通及其取消均獲上市規則第14A.90條全面豁免。
美高梅中國於2024年3月15日宣佈，與其控股股東美高梅國際酒店集團（MRI）簽訂取消函件，自願取消原訂立於2022年11月10日的融通協議下全部7.5億美元的未動用承諾金額。該融通協議於2024年3月20日正式終止，雙方無需承擔任何法律責任，但需按協議條款支付承諾費。此舉是因應澳門放寬COVID-19旅遊限制後市場顯著復甦，以及公司2023年收益大幅增長，故公司商業上無需提取該融通。董事會認為此決定符合公司及股東整體利益，且融通及其取消均獲上市規則第14A.90條全面豁免。
MGM China announced on March 15, 2024 that it has signed a cancellation letter with its controlling shareholder, MGM International Hotels Group (MRI), voluntarily canceling all of the outstanding commitments of USD 7.5 billion under the merger agreement entered into on November 10, 2022. The Merger Agreement was formally terminated on March 20, 2024, and the parties are not liable for any legal liability but are subject to payment of the commitment fee in accordance with the terms of the agreement. The move comes in response to a significant recovery in the market following the easing of COVID-19 travel restrictions in Macau, and the company's revenue growth in 2023, so the company does not need to extract the merger commercially. The Board considers that this decision is in the overall interest of the Company and its shareholders, and the merger and its cancellation are fully exempted from Article 14A.90 of Listing Rules.
MGM China announced on March 15, 2024 that it has signed a cancellation letter with its controlling shareholder, MGM International Hotels Group (MRI), voluntarily canceling all of the outstanding commitments of USD 7.5 billion under the merger agreement entered into on November 10, 2022. The Merger Agreement was formally terminated on March 20, 2024, and the parties are not liable for any legal liability but are subject to payment of the commitment fee in accordance with the terms of the agreement. The move comes in response to a significant recovery in the market following the easing of COVID-19 travel restrictions in Macau, and the company's revenue growth in 2023, so the company does not need to extract the merger commercially. The Board considers that this decision is in the overall interest of the Company and its shareholders, and the merger and its cancellation are fully exempted from Article 14A.90 of Listing Rules.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more